3MJL - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH 2-AMINOIMIDAZOLE. RESOLUTION 1.90 A.

Authors :   L. Di Costanzo, D. W. Christianson

Date :   13 Apr 10 (Deposition) - 05 May 10 (Release) - 05 May 10 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.90

Chains :   Asym. Unit : A,B
Biol. Unit 1: A  (3x)
Biol. Unit 2: B  (3x)

Keywords :   Aminoimidazole Derivatives, Inhibition, Manganese Cluster, Hydrolase, Metal Coordination (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   M. Ilies, L. Di Costanzo, M. L. North, J. A. Scott, D. W. Christianson
Crystal Structure Of Human Arginase I In Complex With 2-Aminoimidazole. Resolution 1. 90 A.
To Be Published
PubMed: search

Molecule 1 - ARGINASE-1
	Chains	:	A, B
	EC Number	:	3.5.3.1
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Plasmid	:	PET-11D
	Expression System Strain	:	BL21 (DE3)
	Expression System Taxid	:	562
	Expression System Vector Type	:	PLASMID
	Gene	:	ARG1
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	TYPE I ARGINASE, LIVER-TYPE ARGINASE

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (3x)	:	A
Biological Unit 2 (3x)	:		B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (2, 6)

No.	Name	Count	Type	Full Name
1	2AI	2	Ligand/Ion	1H-IMIDAZOL-2-AMINE
2	MN	4	Ligand/Ion	MANGANESE (II) ION

Biological Unit 1 (1, 3)

No.	Name	Count	Type	Full Name
1	2AI	3	Ligand/Ion	1H-IMIDAZOL-2-AMINE
2	MN	-1	Ligand/Ion	MANGANESE (II) ION

Biological Unit 2 (1, 3)

No.	Name	Count	Type	Full Name
1	2AI	3	Ligand/Ion	1H-IMIDAZOL-2-AMINE
2	MN	-1	Ligand/Ion	MANGANESE (II) ION

Asymmetric Unit (6, 6)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	ASP A:124 , HIS A:126 , ASP A:232 , ASP A:234 , MN A:3315 , HOH A:9164	BINDING SITE FOR RESIDUE MN A 3314
2	AC2	SOFTWARE	HIS A:101 , ASP A:124 , ASP A:128 , ASP A:232 , MN A:3314 , HOH A:9163 , HOH A:9164	BINDING SITE FOR RESIDUE MN A 3315
3	AC3	SOFTWARE	HIS A:126 , ASP A:128 , GLY A:142 , THR A:246 , HOH A:9109 , HOH A:9171 , HOH A:9207	BINDING SITE FOR RESIDUE 2AI A 5001
4	AC4	SOFTWARE	ASP B:124 , HIS B:126 , ASP B:232 , ASP B:234 , MN B:4315 , HOH B:9110 , HOH B:9161	BINDING SITE FOR RESIDUE MN B 4314
5	AC5	SOFTWARE	HIS B:101 , ASP B:124 , ASP B:128 , ASP B:232 , MN B:4314 , HOH B:9161 , HOH B:9162	BINDING SITE FOR RESIDUE MN B 4315
6	AC6	SOFTWARE	HIS B:141 , HOH B:9110	BINDING SITE FOR RESIDUE 2AI B 5000

(no "SS Bond" information available for 3MJL)

Asymmetric Unit

No.	Residues
1	Gly A:98	-	Gly A:99
2	Gly B:98	-	Gly B:99

Asymmetric Unit (10, 20)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_015594	I	11	T	ARGI1_HUMAN	Disease (ARGIN)	28941474	A/B	I	11	T
02	UniProt	VAR_072164	G	27	D	ARGI1_HUMAN	Disease (ARGIN)	---	A/B	G	27	D
03	UniProt	VAR_072165	G	74	V	ARGI1_HUMAN	Disease (ARGIN)	---	A/B	G	74	V
04	UniProt	VAR_072166	A	125	V	ARGI1_HUMAN	Disease (ARGIN)	---	A/B	A	125	V
05	UniProt	VAR_072167	T	134	I	ARGI1_HUMAN	Disease (ARGIN)	---	A/B	T	134	I
06	UniProt	VAR_015595	G	138	V	ARGI1_HUMAN	Disease (ARGIN)	104893943	A/B	G	138	V
07	UniProt	VAR_072168	R	180	T	ARGI1_HUMAN	Disease (ARGIN)	---	A/B	R	180	T
08	UniProt	VAR_000674	G	235	R	ARGI1_HUMAN	Disease (ARGIN)	104893948	A/B	G	235	R
09	UniProt	VAR_000675	T	290	S	ARGI1_HUMAN	Polymorphism	104893942	A/B	T	290	S
10	UniProt	VAR_072169	R	308	Q	ARGI1_HUMAN	Disease (ARGIN)	377280518	A/B	R	308	Q

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (10, 30)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_015594	I	11	T	ARGI1_HUMAN	Disease (ARGIN)	28941474	A	I	11	T
02	UniProt	VAR_072164	G	27	D	ARGI1_HUMAN	Disease (ARGIN)	---	A	G	27	D
03	UniProt	VAR_072165	G	74	V	ARGI1_HUMAN	Disease (ARGIN)	---	A	G	74	V
04	UniProt	VAR_072166	A	125	V	ARGI1_HUMAN	Disease (ARGIN)	---	A	A	125	V
05	UniProt	VAR_072167	T	134	I	ARGI1_HUMAN	Disease (ARGIN)	---	A	T	134	I
06	UniProt	VAR_015595	G	138	V	ARGI1_HUMAN	Disease (ARGIN)	104893943	A	G	138	V
07	UniProt	VAR_072168	R	180	T	ARGI1_HUMAN	Disease (ARGIN)	---	A	R	180	T
08	UniProt	VAR_000674	G	235	R	ARGI1_HUMAN	Disease (ARGIN)	104893948	A	G	235	R
09	UniProt	VAR_000675	T	290	S	ARGI1_HUMAN	Polymorphism	104893942	A	T	290	S
10	UniProt	VAR_072169	R	308	Q	ARGI1_HUMAN	Disease (ARGIN)	377280518	A	R	308	Q

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (10, 30)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_015594	I	11	T	ARGI1_HUMAN	Disease (ARGIN)	28941474	B	I	11	T
02	UniProt	VAR_072164	G	27	D	ARGI1_HUMAN	Disease (ARGIN)	---	B	G	27	D
03	UniProt	VAR_072165	G	74	V	ARGI1_HUMAN	Disease (ARGIN)	---	B	G	74	V
04	UniProt	VAR_072166	A	125	V	ARGI1_HUMAN	Disease (ARGIN)	---	B	A	125	V
05	UniProt	VAR_072167	T	134	I	ARGI1_HUMAN	Disease (ARGIN)	---	B	T	134	I
06	UniProt	VAR_015595	G	138	V	ARGI1_HUMAN	Disease (ARGIN)	104893943	B	G	138	V
07	UniProt	VAR_072168	R	180	T	ARGI1_HUMAN	Disease (ARGIN)	---	B	R	180	T
08	UniProt	VAR_000674	G	235	R	ARGI1_HUMAN	Disease (ARGIN)	104893948	B	G	235	R
09	UniProt	VAR_000675	T	290	S	ARGI1_HUMAN	Polymorphism	104893942	B	T	290	S
10	UniProt	VAR_072169	R	308	Q	ARGI1_HUMAN	Disease (ARGIN)	377280518	B	R	308	Q

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (1, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ARGINASE_1	PS01053	Arginase family signature.	ARGI1_HUMAN	230-251	2	A:230-251 B:230-251

Biological Unit 1 (1, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ARGINASE_1	PS01053	Arginase family signature.	ARGI1_HUMAN	230-251	3	A:230-251 -

Biological Unit 2 (1, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ARGINASE_1	PS01053	Arginase family signature.	ARGI1_HUMAN	230-251	3	- B:230-251

Asymmetric Unit (8, 16)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000368087	1a	ENSE00001873351	chr6:131894284-131894479	196	ARGI1_HUMAN	1-19	19	2	A:6-19 B:6-19	14 14
1.2b	ENST00000368087	2b	ENSE00002142788	chr6:131897803-131897875	73	ARGI1_HUMAN	20-44	25	2	A:20-44 B:20-44	25 25
1.3d	ENST00000368087	3d	ENSE00002187903	chr6:131900251-131900425	175	ARGI1_HUMAN	44-102	59	2	A:44-102 B:44-102	59 59
1.4c	ENST00000368087	4c	ENSE00002164252	chr6:131902359-131902518	160	ARGI1_HUMAN	102-155	54	2	A:102-155 B:102-155	54 54
1.5a	ENST00000368087	5a	ENSE00002158516	chr6:131903761-131903855	95	ARGI1_HUMAN	156-187	32	2	A:156-187 B:156-187	32 32
1.6b	ENST00000368087	6b	ENSE00002147839	chr6:131904200-131904304	105	ARGI1_HUMAN	187-222	36	2	A:187-222 B:187-222	36 36
1.7c	ENST00000368087	7c	ENSE00000798683	chr6:131904495-131904631	137	ARGI1_HUMAN	222-268	47	2	A:222-268 B:222-268	47 47
1.8b	ENST00000368087	8b	ENSE00001836591	chr6:131904882-131905472	591	ARGI1_HUMAN	268-322	55	2	A:268-319 B:268-318	52 51

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:314
 aligned with ARGI1_HUMAN | P05089 from UniProtKB/Swiss-Prot  Length:322

    Alignment length:314
                                    15        25        35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315    
          ARGI1_HUMAN     6 RTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLN 319
               SCOP domains d3mjla_ A: Arginase                                                                                                                                                                                                                                                                                                        SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeeeee........hhhhhhhhhhhhhhhhhhhhhhh..eeeeeee................hhhhhhhhhhhhhhhhhhhhhh..eeeee..hhhhhhhhhhhhhhhh...eeeee...............hhhhhhhhhhhhhhh................hhh.eeeeee...hhhhhhhhhhh..eeeehhhhhhhhhhhhhhhhhhhhhh.....eeeeee.hhh................hhhhhhhhhhhhhhhh.eeeeeee..hhhhh.hhhhhhhhhhhhhhhhhhh................ Sec.struct. author
                 SAPs(SNPs) -----T---------------D----------------------------------------------V--------------------------------------------------V--------I---V-----------------------------------------T------------------------------------------------------R------------------------------------------------------S-----------------Q----------- SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ARGINASE_1            -------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     Exon 1.2b  PDB: A:20-44  ---------------------------------------------------------Exon 1.4c  PDB: A:102-155 UniProt: 102-155            Exon 1.5a  PDB: A:156-187       ----------------------------------Exon 1.7c  PDB: A:222-268 UniProt: 222-268     --------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.3d  PDB: A:44-102 UniProt: 44-102                   ------------------------------------------------------------------------------------Exon 1.6b  PDB: A:187-222           ---------------------------------------------Exon 1.8b  PDB: A:268-319 UniProt: 268-322           Transcript 1 (2)
                 3mjl A   6 RTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLN 319
                                    15        25        35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315

Chain B from PDB  Type:PROTEIN  Length:313
 aligned with ARGI1_HUMAN | P05089 from UniProtKB/Swiss-Prot  Length:322

    Alignment length:313
                                    15        25        35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315   
          ARGI1_HUMAN     6 RTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYL 318
               SCOP domains d3mjlb_ B: Arginase                                                                                                                                                                                                                                                                                                       SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) Arginase-3mjlB01 B:6-305                                                                                                                                                                                                                                                                                    ------------- Pfam domains (1)
           Pfam domains (2) Arginase-3mjlB02 B:6-305                                                                                                                                                                                                                                                                                    ------------- Pfam domains (2)
         Sec.struct. author .eeeeee........hhhhhhhhhhhhhhhhhhhhhhh..eeeeeee................hhhhhhhhhhhhhhhhhhhhhh..eeeee..hhhhhhhhhhhhhh.....eeeee...............hhhhhhhhhhhhhhh................hhh.eeee.....hhhhhhhhhhhh.eeehhhhhhhhhhhhhhhhhhhhhhh.....eeeeee.hhh................hhhhhhhhhhhhhhhh.eeeeeee..hhhhh.hhhhhhhhhhhhhhhhhhhh.............. Sec.struct. author
                 SAPs(SNPs) -----T---------------D----------------------------------------------V--------------------------------------------------V--------I---V-----------------------------------------T------------------------------------------------------R------------------------------------------------------S-----------------Q---------- SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ARGINASE_1            ------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     Exon 1.2b  PDB: B:20-44  ---------------------------------------------------------Exon 1.4c  PDB: B:102-155 UniProt: 102-155            Exon 1.5a  PDB: B:156-187       ----------------------------------Exon 1.7c  PDB: B:222-268 UniProt: 222-268     -------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.3d  PDB: B:44-102 UniProt: 44-102                   ------------------------------------------------------------------------------------Exon 1.6b  PDB: B:187-222           ---------------------------------------------Exon 1.8b  PDB: B:268-318 UniProt: 268-322          Transcript 1 (2)
                 3mjl B   6 RTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYL 318
                                    15        25        35        45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a/b) (23833)

Fold: Arginase/deacetylase (138)

Superfamily: Arginase/deacetylase (138)

Family: Arginase-like amidino hydrolases (97)

Protein domain: Arginase (73)

Human (Homo sapiens) [TaxId: 9606] (26)

1a	d3mjla_	A:
1b	d3mjlb_	B:

(no "CATH Domain" information available for 3MJL)

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Arginase (56)

Family: Arginase (37)

Homo sapiens (Human) (11)

1a	Arginase-3mjlB01	B:6-305
1b	Arginase-3mjlB02	B:6-305

Asymmetric Unit(hide GO term definitions)

Chain A,B (ARGI1_HUMAN | P05089)

molecular function
	GO:0004053	arginase activity	Catalysis of the reaction: L-arginine + H2O = L-ornithine + urea.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016813	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a linear amidine, a compound of the form R-C(=NH)-NH2.
	GO:0030145	manganese ion binding	Interacting selectively and non-covalently with manganese (Mn) ions.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
biological process
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0006527	arginine catabolic process	The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
	GO:0019547	arginine catabolic process to ornithine	The chemical reactions and pathways resulting in the breakdown of arginine into other compounds, including ornithine.
	GO:0006525	arginine metabolic process	The chemical reactions and pathways involving arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
	GO:0071549	cellular response to dexamethasone stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
	GO:0071377	cellular response to glucagon stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
	GO:0070301	cellular response to hydrogen peroxide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
	GO:0071353	cellular response to interleukin-4	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
	GO:0071222	cellular response to lipopolysaccharide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0071560	cellular response to transforming growth factor beta stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
	GO:0032964	collagen biosynthetic process	The chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
	GO:0007565	female pregnancy	The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
	GO:0001889	liver development	The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
	GO:0030324	lung development	The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
	GO:0060056	mammary gland involution	The tissue remodeling that removes differentiated mammary epithelia during weaning.
	GO:0060135	maternal process involved in female pregnancy	A reproductive process occurring in the mother that allows an embryo or fetus to develop within it.
	GO:0001938	positive regulation of endothelial cell proliferation	Any process that activates or increases the rate or extent of endothelial cell proliferation.
	GO:0070207	protein homotrimerization	The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
	GO:0010963	regulation of L-arginine import	Any process that modulates the frequency, rate or extent of L-arginine import. L-arginine import is the directed movement of L-arginine, the L-enantiomer of 2-amino-5-guanidinopentanoic acid, into a cell or organelle.
	GO:0014075	response to amine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amine stimulus. An amine is a compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
	GO:0043200	response to amino acid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
	GO:0048678	response to axon injury	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
	GO:0046686	response to cadmium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0009635	response to herbicide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a herbicide stimulus. Herbicides are chemicals used to kill or control the growth of plants.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0010042	response to manganese ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus.
	GO:0051597	response to methylmercury	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylmercury stimulus.
	GO:0043434	response to peptide hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
	GO:0010269	response to selenium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from selenium ion.
	GO:0048545	response to steroid hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
	GO:0033189	response to vitamin A	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.
	GO:0033197	response to vitamin E	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus.
	GO:0009611	response to wounding	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
	GO:0010043	response to zinc ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
	GO:0000050	urea cycle	The sequence of reactions by which arginine is synthesized from ornithine, then cleaved to yield urea and regenerate ornithine. The overall reaction equation is NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005741	mitochondrial outer membrane	The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
	GO:0043005	neuron projection	A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
	GO:0043025	neuronal cell body	The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		2AI	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gly A:98 - Gly A:99	[ RasMol ]
		Gly B:98 - Gly B:99	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3mjl
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ARGI1_HUMAN \| P05089
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.5.3.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	207800
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ARGI1_HUMAN \| P05089
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

3mfv	CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH 2- AMINOHOMOHISTIDINE
3mfw	CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH L-2- AMINOHISTIDINE AND SULPHATE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 6)

Sites (6, 6)

SS Bonds (0, 0)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (10, 20)

PROSITE Motifs (1, 2)

Exons (8, 16)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (0, 0)

Pfam Domains (1, 2)

Gene Ontology (49, 49)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File